Join us for a Radiology Business webinar and live Q&A on Tuesday, April 21, with leaders from this seven-center imaging group and a veteran financial expert.
Almost 15% of more than 5,500 U.S. adults—representing around 14 million individuals—have skipped a doctor visit after feeling satisfied enough with health advice they received from AI.
Demonstrated cost-effectiveness is a highly motivating factor in getting healthcare workers to adopt measures for preventing and controlling healthcare-associated infections.
The product, which is offered within Elucid’s novel Plaque-IQ software suite, allows physicians to analyze lesion composition and plaque burden across any vessel.
The risk appears to be greatest when patients are still actively taking antidepressants. Researchers noted that many more studies on this topic are still necessary.
The deal includes an upfront payment of $20 million. Stereotaxis could pay up to an additional $25 million if certain regulatory and commercial milestones are met.
According to Heartflow, Cleerly's actions represent “one of the most egregious examples of piracy in the medical technology industry.” Cleerly commented on the lawsuit, defending the value and integrity of its products.
If the budget makes it through Congress intact as submitted—a big if even with the president’s party in the majority in both chambers—healthcare is in for some strict belt-tightening.
Join us for a Radiology Business webinar and live Q&A on Tuesday, April 21, with leaders from this seven-center imaging group and a veteran financial expert.
